Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma. A Phase I and Phase II Study.

NCT01959438 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT01959438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01959438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma. A Phase I and Phase II Study.
Lead sponsor
Karolinska University Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 28, 2007
Completion date
June 30, 2018
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumor, treatment resistant disorders, tumor progression